ConductScience.org, home

Trial · NCT01502306

A Randomized Trial of Medi-Cal Beneficiaries Calling the California Smokers' Helpline

NCT01502306, Phase 3, Completed, University of California, San Diego; results first posted 2019-10-01

3 sourcestrials-2026-11-12-0.5.0

Download JSON
Cite this record

ConductScience Library. A Randomized Trial of Medi-Cal Beneficiaries Calling the California Smokers' Helpline. Trials, record NCT01502306. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT01502306

On this page

Trial

As registered on ClinicalTrials.gov, in the graph's capture of the registry.

Title
A Randomized Trial of Medi-Cal Beneficiaries Calling the California Smokers' Helpline
NCT number
NCT01502306
Status
Completed
Phases
Phase 3
Enrollment
3,816 participants, actual
Lead sponsor
University of California, San Diego
Conditions
Smoking Cessation
Interventions
Telephone counseling, Nicotine patches, Incentive
First posted
2011-12-30
Last updated
2020-02-13
Results first posted
2019-10-01

Source ClinicalTrials.gov

Registered outcomes4

Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.

ListOutcomeTime frameDescription
Primary30-day Abstinence7 months post enrollment
At a given point in time (in this case, 7 months after program registration), quitline participants are asked whether they have used cigarettes or other forms of tobacco in the past 30 days. Those who reply that they have not used tobacco in the past 30 days are considered to have quit.
SecondaryPercentage of Smokers Making a 24-hour Quit Attempt2 months post enrollmentAt a given point in time (in this case, 2 months after program registration), quitline participants are asked whether they made a quit attempt (attempt at quitting smoking) and how long they made it.
SecondaryContinuous Abstinence Rates for Those Who Made Quit Attempts7-months post enrollmentNot smoking since the quit date
Secondary7-day Prevalence.7-months post enrollment
Seven-day point prevalence abstinence is a measure of, in this case, tobacco cessation outcomes for quitlines. At a given point in time (in this case, 7 months after program registration), quitline participants are asked whether they have used cigarettes or other forms of tobacco in the past 7 days.

Outcomes4

Each outcome the trial posted results for, in ClinicalTrials.gov's words.

TypeOutcomeTime framePopulationUnitsMeasured as
PRIMARY30-day Abstinence7 months post enrollmentNumber of participants analyzed reflects the number of participants the quitline was able to reach at 7-monthsParticipantsCOUNT_OF_PARTICIPANTS
SECONDARYPercentage of Smokers Making a 24-hour Quit Attempt2 months post enrollmentNumber of participants analyzed reflects the number of participants the quitline was able to reach at 2-monthsParticipantsCOUNT_OF_PARTICIPANTS
SECONDARYContinuous Abstinence Rates for Those Who Made Quit Attempts7-months post enrollmentNumber of participants analyzed reflects the number of participants the quitline was able to reach at 7-monthsParticipantsCOUNT_OF_PARTICIPANTS
SECONDARY7-day Prevalence.7-months post enrollmentNumber of participants analyzed reflects the number of participants the quitline was able to reach at 7-monthsParticipantsCOUNT_OF_PARTICIPANTS

Results by group12

Each measurement the trial posted, group by group, in the words and numbers it posted.

OutcomeGroupCategoryValueSpreadUnits
30-day AbstinenceTelephone Counseling168Participants
30-day AbstinencePhone Counseling & Nicotine Patches237Participants
30-day AbstinencePhone Counseling, NRT and Incentives302Participants
Percentage of Smokers Making a 24-hour Quit AttemptTelephone Counseling546Participants
Percentage of Smokers Making a 24-hour Quit AttemptPhone Counseling & Nicotine Patches847Participants
Percentage of Smokers Making a 24-hour Quit AttemptPhone Counseling, NRT and Incentives962Participants
Continuous Abstinence Rates for Those Who Made Quit AttemptsTelephone Counseling90Participants
Continuous Abstinence Rates for Those Who Made Quit AttemptsPhone Counseling & Nicotine Patches145Participants
Continuous Abstinence Rates for Those Who Made Quit AttemptsPhone Counseling, NRT and Incentives185Participants
7-day Prevalence.Telephone Counseling162Participants

Participant flow9

How many started, completed or left each group, period by period.

PeriodMilestoneGroupParticipantsUnits counted
Overall StudySTARTEDTelephone Counseling1,004
Overall StudySTARTEDPhone Counseling & Nicotine Patches1,405
Overall StudySTARTEDPhone Counseling, NRT and Incentives1,407
Overall StudyCOMPLETEDTelephone Counseling1,004
Overall StudyCOMPLETEDPhone Counseling & Nicotine Patches1,405
Overall StudyCOMPLETEDPhone Counseling, NRT and Incentives1,407
Overall StudyNOT COMPLETEDTelephone Counseling0
Overall StudyNOT COMPLETEDPhone Counseling & Nicotine Patches0
Overall StudyNOT COMPLETEDPhone Counseling, NRT and Incentives0

Adverse events0

Each adverse event the trial posted, group by group: the participants affected out of those at risk.

None in this release.

Adverse event totals9

The totals the trial posted for each group.

TotalGroupAffectedAt risk
Total, all-cause mortalityTelephone Counseling
Total, all-cause mortalityPhone Counseling & Nicotine Patches
Total, all-cause mortalityPhone Counseling, NRT and Incentives
Total, other adverse eventsTelephone Counseling01,004
Total, other adverse eventsPhone Counseling & Nicotine Patches01,405
Total, other adverse eventsPhone Counseling, NRT and Incentives01,407
Total, serious adverse eventsTelephone Counseling01,004
Total, serious adverse eventsPhone Counseling & Nicotine Patches01,405
Total, serious adverse eventsPhone Counseling, NRT and Incentives01,407

Papers5

The papers the trial lists on ClinicalTrials.gov.

PMIDListed asSource
8907100BACKGROUNDPubMed
12362011BACKGROUNDPubMed
18048638BACKGROUNDPubMed
22094998BACKGROUNDPubMed
30454668DERIVEDPubMed

Grants0

The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.

None in this release.

Trial comparisons0

Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.

None in this release.

Tests0

The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.

None in this release.

Data dates

The day each source was copied for this release.

ClinicalTrials.gov
2026-11-12
ClinicalTrials.gov
Results, from AACT
2026-03-23
AACT
NIH grant links
2026-11-13
NIH RePORTER

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this trial from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/trials/v1/NCT01502306

GET https://conductscience.org/api/trials/v1/NCT01502306/registered